caffeine has been researched along with Allergic Encephalomyelitis in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Caffeine treatment augmented A1AR expression on microglia, with ensuing reduction of EAE severity, which was further enhanced by concomitant treatment with the A1AR agonist, adenosine amine congener." | 5.32 | A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. ( Henry, S; Noorbakhsh, F; Power, C; Schnermann, J; Tsutsui, S; Warren, K; Winston, BW; Yong, VW, 2004) |
| "Caffeine treatment augmented A1AR expression on microglia, with ensuing reduction of EAE severity, which was further enhanced by concomitant treatment with the A1AR agonist, adenosine amine congener." | 1.32 | A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. ( Henry, S; Noorbakhsh, F; Power, C; Schnermann, J; Tsutsui, S; Warren, K; Winston, BW; Yong, VW, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, HQ | 1 |
| Song, KY | 1 |
| Feng, JZ | 1 |
| Huang, SY | 1 |
| Guo, XM | 1 |
| Zhang, L | 1 |
| Zhang, G | 1 |
| Huo, YC | 1 |
| Zhang, RR | 1 |
| Ma, Y | 1 |
| Hu, QZ | 1 |
| Qin, XY | 1 |
| Evans, E | 1 |
| Piccio, L | 1 |
| Cross, AH | 1 |
| Wang, T | 1 |
| Xi, NN | 1 |
| Chen, Y | 1 |
| Shang, XF | 1 |
| Hu, Q | 1 |
| Chen, JF | 2 |
| Zheng, RY | 2 |
| Chen, GQ | 1 |
| Chen, YY | 1 |
| Wang, XS | 1 |
| Wu, SZ | 1 |
| Yang, HM | 1 |
| Xu, HQ | 1 |
| He, JC | 1 |
| Wang, XT | 1 |
| Tsutsui, S | 1 |
| Schnermann, J | 1 |
| Noorbakhsh, F | 1 |
| Henry, S | 1 |
| Yong, VW | 1 |
| Winston, BW | 1 |
| Warren, K | 1 |
| Power, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Adjuvant Effects of Vitamin A and Vitamin D Supplementation on Treatment of Children With ADHD:A Randomized, Double Blind, Placebo-controlled, Multicentric Trial.[NCT04284059] | Phase 4 | 504 participants (Anticipated) | Interventional | 2021-02-25 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for caffeine and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Use of Vitamins and Dietary Supplements by Patients With Multiple Sclerosis: A Review.
Topics: Acetylcarnitine; Animals; Ascorbic Acid; Biotin; Caffeine; Creatine; Curcumin; Dietary Supplements; | 2018 |
4 other studies available for caffeine and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Caffeine Inhibits Activation of the NLRP3 Inflammasome via Autophagy to Attenuate Microglia-Mediated Neuroinflammation in Experimental Autoimmune Encephalomyelitis.
Topics: Animals; Autophagy; Caffeine; Encephalomyelitis, Autoimmune, Experimental; Inflammasomes; Mice; Mice | 2022 |
Chronic caffeine treatment protects against experimental autoimmune encephalomyelitis in mice: therapeutic window and receptor subtype mechanism.
Topics: Animals; Brain; Caffeine; Cytokines; Disease Progression; Encephalomyelitis, Autoimmune, Experimenta | 2014 |
Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats.
Topics: Animals; Caffeine; Central Nervous System; Cytokines; Disease Models, Animal; Dose-Response Relation | 2010 |
A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Caffeine; Disease Models, Animal; Disease Progre | 2004 |